PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Okyanos Heart Institute

Press Release


Receive press releases from Okyanos Heart Institute: By Email RSS Feeds:

Okyanos Heart Institute Chief Executive Officer to Speak at the Strategic Forum Meeting Oct. 26


CEO Matt Feshbach Will Join Other Business Leaders as Forum Guest Speaker

Freeport, Bahamas, The, October 12, 2012 --(PR.com)-- Okyanos Heart Institute (http://www.okyanos.com/), which brings a new standard of care and a better quality of life to patients with coronary artery disease (CAD) using cardiac cell therapy, announces that Matt Feshbach, CEO, will serve as a guest speaker at The Strategic Forum meeting on Friday, Oct. 26. The meeting will take place at Nova Southeastern University’s H. Wayne Huizenga School of Business in the Amaturo Board Room located at 3301 College Ave. in Ft. Lauderdale, Fla. Attendees will enjoy breakfast and networking from 7:30 a.m. to 8 a.m., followed by the forum from 8 a.m. to 10:30 a.m.

Feshbach will join three other business leaders and provide insight on his experience as the CEO of Okyanos Heart Institute in an effort to promote business collaboration. The Strategic Forum is an organization of business leaders from diverse backgrounds dedicated to the exchange of ideas, development of long-term personal and business relationships, and the facilitation of business opportunities among its members and their respective networks. Other guest speakers include Tere Blanca, CEO of Blanca Commercial Real Estate; Jeff Bartel, chairman of Benworth Capital Partners; and Patrick Savage, founder of BodyLogicMD.

Quotes:
“Forums such as this provide exciting opportunities for networking and collaboration that benefit business operations and leadership,” said Feshbach. “As an institute serving the public, it is important that we position ourselves in a way that allows us to better serve chronic coronary artery disease patients and provide them with a better quality of life, and I remain dedicated to doing anything and everything I can to ensure that our patients receive the best treatment possible.”

“Matt’s direction and leadership serves as the guiding force for Okyanos Heart Institute as we strive to provide the highest quality of care to our patients,” said Howard T. Walpole Jr., M.D., MBA, FACC, FACAI, FSCAI and chief medical officer for Okyanos Heart Institute. “We look forward to Matt sharing his insight with other business leaders as well as participate in the exchange of ideas that will take place at a forum such as this.”

Details:
- For more information about The Strategic Forum, visit http://bit.ly/QHq13E.

New Media Content:
Okyanos Blog:
http://bit.ly/Prsdux

Okyanos LinkedIn page:
http://linkd.in/Prsgqd

Okyanos Facebook page:
http://on.fb.me/TKiXTi

Okyanos Twitter page:
http://bit.ly/OFZPqk

About Okyanos Heart Institute:
Based in Freeport, the Bahamas, the Okyanos Heart Institute is a Center of Excellence (CoE) adhering to U.S. surgical center standards and led by Chief Medical Officer Howard T. Walpole Jr., M.D., MBA, FACC, FACAI, FSCAI, a leader of the American College of Cardiology for many years. The mission of Okyanos Heart Institute is to bring a new standard of care and a better quality of life to patients with chronic coronary artery disease using cardiac cell therapy. The Okyanos treatment utilizes cardiac cell therapy, a unique blend of stem and regenerative cells to support the growth of new blood vessels and to assist the heart in repairing tissue damaged by heart attack and disease. The Greek god of rivers, “Okyanos” symbolizes the primary mechanism of action that these adult stem cells have on ischemic (lack of blood flow) heart tissue, the result of the plaque deposits in the coronary arteries. The stem cells, derived from a person’s adipose (fat) tissue, create new blood vessels, a process known as angiogenesis. These cells facilitate blood flow in the heart and intake and use of oxygen, as measured by a rigorous clinical trial known as the PRECISE trial, as well as cardiac cell therapy trials at leading research institutions. For more information, visit http://www.okyanos.com/.

Anjelica Cummings
MMI Public Relations
(919) 233-6600
anjelica@mmipublicrelations.com
http://twitter.com/MMIPR
http://www.mmipublicrelations.com
Contact Information
Okyanos Heart Institute
Patty Briguglio
919-233-6600
Contact

Click here to view the list of recent Press Releases from Okyanos Heart Institute
Promote Your Business